Holen Sie sich die Stockscreener-App
30.44
5.84%
1.68
Handel nachbörslich:
30.20
-0.24
-0.79%
Schlusskurs vom Vortag:
$28.76
Offen:
$28.745
24-Stunden-Volumen:
17,863
Relative Volume:
0.35
Marktkapitalisierung:
$285.45M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.55%
1M Leistung:
+15.57%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$28.75
$30.65
1-Wochen-Bereich:
$28.20
$30.69
52-Wochen-Spanne:
$15.80
$34.31
Tvardi Therapeutics Inc Stock (TVRD) Company Profile
Firmenname
Tvardi Therapeutics Inc
Sektor
Branche
Telefon
(713) 489-8654
Adresse
3 SUGAR CREEK CTR. BLVD., SUGAR LAND
Vergleichen Sie TVRD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TVRD
Tvardi Therapeutics Inc
|
30.44 | 277.38M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Tvardi Therapeutics Inc Stock (TVRD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-14 | Eingeleitet | Raymond James | Outperform |
| 2025-07-11 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-06-12 | Eingeleitet | Piper Sandler | Overweight |
| 2025-05-21 | Eingeleitet | Oppenheimer | Outperform |
| 2025-05-15 | Eingeleitet | BTIG Research | Buy |
| 2024-06-13 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-06-13 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-06-13 | Herabstufung | Needham | Buy → Hold |
| 2024-06-13 | Herabstufung | Stifel | Buy → Hold |
| 2023-03-08 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-03-08 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-11-01 | Fortgesetzt | Canaccord Genuity | Buy |
| 2021-08-03 | Eingeleitet | JP Morgan | Neutral |
| 2020-04-21 | Bestätigt | H.C. Wainwright | Buy |
| 2019-08-12 | Bestätigt | H.C. Wainwright | Buy |
| 2019-05-29 | Bestätigt | Laidlaw | Buy |
| 2019-02-06 | Fortgesetzt | Jefferies | Buy |
| 2019-01-15 | Eingeleitet | BofA/Merrill | Neutral |
| 2018-09-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-09-13 | Eingeleitet | Jefferies | Buy |
| 2018-08-08 | Bestätigt | Stifel | Buy |
| 2018-06-28 | Bestätigt | H.C. Wainwright | Buy |
| 2018-03-12 | Fortgesetzt | H.C. Wainwright | Buy |
| 2018-02-12 | Hochstufung | Janney | Neutral → Buy |
| 2018-01-19 | Eingeleitet | Seaport Global Securities | Buy |
Alle ansehen
Tvardi Therapeutics Inc Aktie (TVRD) Neueste Nachrichten
What are Tvardi Therapeutics Inc.’s technical support levelsEarnings Growth Summary & Risk Adjusted Buy/Sell Alerts - khodrobank.com
Visual trend scoring systems applied to Tvardi Therapeutics Inc.Quarterly Profit Review & Daily Oversold Bounce Ideas - Newser
What’s Tvardi Therapeutics Inc.’s historical returnShare Buyback & Consistent Return Investment Signals - khodrobank.com
Will breakout in Tvardi Therapeutics Inc. lead to full recoveryJuly 2025 Big Picture & High Return Stock Watch Alerts - Newser
Published on: 2025-09-03 09:20:00 - Newser
Is now a turning point for Tvardi Therapeutics Inc.Weekly Risk Report & Verified Entry Point Signals - Newser
Is Tvardi Therapeutics Inc. stock poised for growthMarket Performance Summary & Weekly High Potential Alerts - Newser
How to read the order book for Tvardi Therapeutics Inc.Buy Signal & Accurate Entry/Exit Alerts - Newser
What momentum shifts mean for Tvardi Therapeutics Inc.2025 Risk Factors & Expert Approved Trade Ideas - Newser
Can trapped investors hope for a rebound in Tvardi Therapeutics Inc.2025 EndofYear Setup & Free Fast Gain Swing Trade Alerts - Newser
Market Overview: Can Tvardi Therapeutics Inc. deliver consistent EPS growthPortfolio Return Summary & High Conviction Buy Zone Alerts - khodrobank.com
Is it too late to sell Tvardi Therapeutics Inc.Earnings Trend Report & Daily Profit Maximizing Tips - Newser
What’s the RSI of Tvardi Therapeutics Inc. stockQuarterly Earnings Summary & Consistent Profit Trading Strategies - khodrobank.com
Does Tvardi Therapeutics Inc. qualify in momentum factor screeningTrade Analysis Report & Daily Risk Controlled Trade Plans - Newser
Short interest data insights for Tvardi Therapeutics Inc.Take Profit & Long-Term Capital Growth Strategies - Newser
What recovery options are there for Tvardi Therapeutics Inc.July 2025 PreEarnings & AI Enhanced Trading Alerts - Newser
Identifying reversal signals in Tvardi Therapeutics Inc.Market Movement Recap & High Accuracy Buy Signal Tips - Newser
Real time social sentiment graph for Tvardi Therapeutics Inc.Quarterly Portfolio Summary & Stepwise Trade Signal Implementation - Newser
What are the analyst revisions for Tvardi Therapeutics Inc.Is QNST stock a good investment in YEAR2025 Dividend Review & AI Based Trade Execution Alerts - khodrobank.com
Tvardi Therapeutics Inc. Included in Top Momentum Scan getLinesFromResByArray error: size == 0 - thegnnews.com
Why Tvardi Therapeutics Inc. is moving todayJuly 2025 Macro Moves & Low Risk High Win Rate Stock Picks - Newser
Can Tvardi Therapeutics Inc. deliver consistent EPS growthMarket Performance Summary & Free Long-Term Investment Growth Plans - khodrobank.com
How to use Fibonacci retracement on Tvardi Therapeutics Inc.Weekly Gains Summary & Risk Adjusted Buy/Sell Alerts - Newser
Applying Elliott Wave Theory to Tvardi Therapeutics Inc.Inflation Watch & Free Expert Verified Stock Movement Alerts - Newser
Tvardi Therapeutics Inc. stock chart pattern explainedQuarterly Trade Review & High Conviction Buy Zone Alerts - Newser
Can Tvardi Therapeutics Inc. recover in the next quarter2025 EndofYear Setup & Accurate Entry and Exit Point Alerts - Newser
Is Tvardi Therapeutics Inc. reversing from oversold territory2025 Key Lessons & Expert Approved Momentum Trade Ideas - Newser
Tvardi Therapeutics (NASDAQ:TVRD) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
Tvardi Therapeutics Faces Legal and Financial Risks from Exclusive Forum Provision - MSN
Volatility clustering patterns for Tvardi Therapeutics Inc.2025 AllTime Highs & Safe Capital Growth Trade Ideas - Newser
How to manage a losing position in Tvardi Therapeutics Inc.July 2025 Technicals & Low Risk Entry Point Guides - Newser
Finanzdaten der Tvardi Therapeutics Inc-Aktie (TVRD)
Es liegen keine Finanzdaten für Tvardi Therapeutics Inc (TVRD) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Tvardi Therapeutics Inc-Aktie (TVRD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Terrillion Scott | SEC'Y; CHIEF COMPLIANCE & G.C. |
Feb 28 '25 |
Sale |
4.76 |
163 |
776 |
7,190 |
| Posner Christopher | PRESIDENT AND CEO |
Feb 04 '25 |
Sale |
4.72 |
372 |
1,756 |
13,692 |
| Posner Christopher | PRESIDENT AND CEO |
Nov 04 '24 |
Sale |
0.29 |
3,668 |
1,064 |
168,768 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):